Related Experiment Videos
Oligodendrogliomas: clinical and genetic correlations
1Division of Neurology, Department of Medicine, University of Toronto, Sunnybrook and Women's College Health Science Centre, Room A-442, 2075 Bayview Avenue, Toronto, Ontario, Canada M4N 3M5. james.perry@swchsc.on.ca
Current Opinion in Neurology
|November 28, 2001
Summary
Recent advances in molecular and genetic markers are improving the diagnosis of oligodendroglioma, a common brain tumor. These markers also predict treatment response and survival, aiding clinical practice.
Area of Science:
- Neuro-oncology
- Molecular genetics
- Clinical neurosurgery
Background:
- Oligodendrogliomas are increasingly recognized as common primary brain tumors.
- They exhibit high chemosensitivity among solid human malignancies.
- Recent histopathological, molecular, and genetic findings enable subtype classification of gliomas.
Purpose of the Study:
- To review recent advances in clinical-molecular genetic predictors of glioma behavior.
- To highlight the clinical significance of these predictors in managing oligodendroglioma.
Main Methods:
- Review of current literature on oligodendroglioma genetics and clinical outcomes.
- Analysis of emerging molecular and genetic markers.
- Correlation of genetic markers with diagnosis, treatment response, and survival.
Main Results:
- Genetic markers are crucial for accurate oligodendroglioma diagnosis.
- Specific genetic markers predict patient response to chemotherapy.
- These markers are associated with prolonged survival in glioma patients.
Conclusions:
- Advances in molecular genetics are transforming oligodendroglioma diagnosis and management.
- Clinical-molecular genetic predictors are essential for personalized treatment strategies.
- Integration of these predictors into clinical practice improves patient outcomes.